Sitemap

Technology

Home

Research and Development

Team

Code of Conduct

Products

Human Health

Food Safety

Agriculture

Animal Health

NEWS

Careers

Publications

Investor Relations

Contact

Sitemap side content

NEWS

Micreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus pathogen without triggering resistance

Staphylococcus aureus cells undergoing lysis by the action of XZ.700 PRESS RELEASE ...

Micreos Pharmaceuticals welcomes Trine Ahlgreen and Carsten Edwards to its Executive team to accelerate its next phase of development

PRESS RELEASE Zug, Switzerland, 5-April 2022 — Micreos Pharmaceuticals today a ...

Micreos appoints Joost Goderie as CFO and member of the Board of Directors

PRESS RELEASE The Hague, The Netherlands, January 28, 2022 - Micreos announced that it has ap ...

New clinical study proves safe anti-S. aureus endolysin ‘Staphefekt SA.100’ significantly reduces eczema symptoms

PRESS RELEASE - FOR IMMEDIATE RELEASE The Hague, December 7, 2021.A new study, published in t ...

Micreos appoints Matt Regan as CEO of its Pharmaceutical business

PRESS RELEASE The Hague, October 14, 2021 - Dutch biotechnology company Micreos has recr ...

More news

© 2010 - MICREOS